| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/18/2001 | EP1091726A2 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
| 04/18/2001 | EP0663832B1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
| 04/18/2001 | EP0546160B1 Method of reversing local anesthesia and reagent system therefor |
| 04/18/2001 | CN1292032A Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/18/2001 | CN1291984A Glycine transport inhibitors |
| 04/18/2001 | CN1291983A 6,9-Disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
| 04/18/2001 | CN1291981A Thiophene nitrone compounds |
| 04/18/2001 | CN1291980A thioether furan nitrone compounds |
| 04/18/2001 | CN1291977A Amino anthracyclinone derivatives and their use in treatment of amyloidosis |
| 04/18/2001 | CN1291893A Use of D1/D5 antagonist for treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating desorders, impulse control disorders and autism |
| 04/18/2001 | CN1291892A Substituted oxoazaheterocyclyl factor Xa inhibitors |
| 04/18/2001 | CN1291507A Sobering-up oral liquid |
| 04/18/2001 | CN1291499A Sobering-up composition |
| 04/18/2001 | CN1291493A Drug-dropping composite Chinese medicine and its preparing process |
| 04/18/2001 | CN1291477A Medicinal composition for treating optical atrophy |
| 04/18/2001 | CN1064681C Heterocyclic compounds |
| 04/18/2001 | CN1064674C Alkoxyaryl compounds, their process of preparation and pharmaceutical compositions which contain them |
| 04/18/2001 | CN1064545C Medicinal composition for abstaining from drug and preparing process thereof |
| 04/17/2001 | US6218547 1-phenyl-benzimidazole compounds and their use as GABA-a receptor modulators |
| 04/17/2001 | US6218544 Heterocyclic esters and amides |
| 04/17/2001 | US6218538 Antagonists of n-type neuronal calcium channels useful in the treatment of cerebrovascular ischaemia and pain. |
| 04/17/2001 | US6218537 Process for making pyridyl and pyrimidine substituted imidazole compounds |
| 04/17/2001 | US6218528 MurB |
| 04/17/2001 | US6218526 Polynucleotide encoding human netrin-1 |
| 04/17/2001 | US6218506 Soluble brain protein for the detection, prevention and treatment of alzhiemer's disease |
| 04/17/2001 | US6218430 Vitamin D3 mimics |
| 04/17/2001 | US6218429 Tricyclic compounds, their production and use |
| 04/17/2001 | US6218424 Heterocyclic ketone and thioester compounds and uses |
| 04/17/2001 | US6218423 Administering pyrrolidine derivative for therapy of nerve-related vision disorder, improving vision, treating memory impairment, or enhancing memory performance in animal |
| 04/17/2001 | US6218419 Aminoiminoquinone and aminoquinone alkaloid compounds and methods of use |
| 04/17/2001 | US6218418 Therapy of cell proliferative disorders associated with an altered cell dependent kinase activity by administering amino pyrazole derivative to mammal |
| 04/17/2001 | US6218405 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them |
| 04/17/2001 | US6218402 Antagonizing the serotonin 5ht3 receptor with a pyrrolo quinoline derivative |
| 04/17/2001 | US6218397 For therapy of stress-related illnesses, such as stress-induced depression, anxiety, and headache; abdominal bowel syndrome; inflammatory diseases; immune suppression; alzheimer's disease; gastronintestinal diseases |
| 04/17/2001 | US6218394 4-Aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophene-methyl) piperazines |
| 04/17/2001 | US6218391 Triazinones and derivatives thereof |
| 04/17/2001 | US6218390 Morpholinone and morpholine derivatives and uses thereof |
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |
| 04/17/2001 | US6218385 1,2,4,5-Tetrahydro-benzo[D]azepin derivatives |
| 04/17/2001 | US6218384 3-Oxo-pyrido(1,2-a)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders |
| 04/17/2001 | US6218383 Pharmaceutical compositions for the prevention and treatment of central nervous system disorders |
| 04/17/2001 | US6218113 Human protein kinase C inhibitor |
| 04/17/2001 | US6217904 Pharmaceutical dosage form for pulsatile delivery of d-threo-methylphenidate and a second CNS stimulant |
| 04/17/2001 | US6217898 Pharmaceutical composition comprising carnitine or alkanoyl L-carnitine, for the prevention and treatment of diseases brought about by lipid metabolism disorders |
| 04/17/2001 | US6217877 Extraction using water miscible solvent |
| 04/17/2001 | CA2196054C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 04/17/2001 | CA2158457C Naphthalene derivatives |
| 04/17/2001 | CA2156742C Phosphonomethyldipeptides |
| 04/17/2001 | CA2152267C Difluoro-pentapeptide derivative anti-inflammatory agents |
| 04/17/2001 | CA2080475C Neuroprotective indolone and related derivatives |
| 04/17/2001 | CA2010963C Process for the preparation of lactam derivatives |
| 04/12/2001 | WO2001025486A1 Methods for identifying rna binding compounds |
| 04/12/2001 | WO2001025469A2 Method for preparing steroids modified by yeast fermentation |
| 04/12/2001 | WO2001025442A1 Dna polymerase lambda and uses thereof |
| 04/12/2001 | WO2001025438A2 Ifn-alpha homologues |
| 04/12/2001 | WO2001025437A2 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | WO2001025423A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 04/12/2001 | WO2001025419A1 ALTERING GENE EXPRESSION WITH ssDNA PRODUCED IN VIVO |
| 04/12/2001 | WO2001025269A2 Human g-protein coupled receptor |
| 04/12/2001 | WO2001025265A1 Metal-binding compounds and uses therefor |
| 04/12/2001 | WO2001025258A1 Human inwardly rectifying potassium channel subunit |
| 04/12/2001 | WO2001025257A2 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 04/12/2001 | WO2001025252A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | WO2001025239A2 Oxazinoquinolones useful for the treatment of viral infections |
| 04/12/2001 | WO2001025238A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 04/12/2001 | WO2001025237A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | WO2001025232A1 Process for the preparation of paroxetine hydrochloride acetone solvate |
| 04/12/2001 | WO2001025230A1 Process for the preparation of paroxetine hydrochloride acetone solvate |
| 04/12/2001 | WO2001025229A1 Amide compounds |
| 04/12/2001 | WO2001025219A2 Piperazine compounds |
| 04/12/2001 | WO2001025210A2 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands |
| 04/12/2001 | WO2001025209A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 04/12/2001 | WO2001025207A1 Novel nicotinonitrile compounds |
| 04/12/2001 | WO2001025204A1 Novel trisubstituted pyridine compounds |
| 04/12/2001 | WO2001025188A1 Novel carbamates and ureas |
| 04/12/2001 | WO2001025186A1 Novel ltb4 antagonist, method for the production thereof and its use as a medicament |
| 04/12/2001 | WO2001024831A2 Polymer stabilized neuropeptides |
| 04/12/2001 | WO2001024824A1 Rhodamine derivatives for photodynamic diagnosis and treatment |
| 04/12/2001 | WO2001024823A1 Cd40 antagonist for treating psoriasis |
| 04/12/2001 | WO2001024816A2 Compositions and methods relating to the inhibition of casomorphin and gluteomorphin |
| 04/12/2001 | WO2001024815A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | WO2001024814A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/12/2001 | WO2001024807A2 Method for calming human beings using personal care compositions |
| 04/12/2001 | WO2001024798A1 Use of central cannabinoid receptor antagonist for preparing medicines |
| 04/12/2001 | WO2001024795A1 RETARD FORM CONTAINING α-LIPOIC ACID (DERIVATIVES) |
| 04/12/2001 | WO2001024792A1 Synergistic combinations of an nk1 receptor antagonist and a gaba structural analog |
| 04/12/2001 | WO2001024791A1 Use of synergistic combinations of a nk1 receptor antagonist and a gaba analog in psychiatric disorders |
| 04/12/2001 | WO2001024787A1 Use of xanthophylls, astaxanthin e.g., for treatment of autoimmune diseases, chronic viral and intracellular bacterial infections |
| 04/12/2001 | WO2001024785A2 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases |
| 04/12/2001 | WO2001024784A2 New use |
| 04/12/2001 | WO2001024781A2 Gene necessary for striatal function, uses thereof, and compounds for modulating same |
| 04/12/2001 | WO2001024774A1 Ortho ester lipids |
| 04/12/2001 | WO2001024772A1 Formulation for menopausal women |
| 04/12/2001 | WO2001024764A2 Cell targeting compositions and methods of using the same |
| 04/12/2001 | WO2001024763A2 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 04/12/2001 | WO2001024627A1 Animal with the mass expression of human gene and test method by using the animal |
| 04/12/2001 | WO2001000230A8 Drug composition containing lecithin-modified superoxide dismutase |
| 04/12/2001 | WO2000076958A3 Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
| 04/12/2001 | WO2000071533A3 1,4-dithiin and 1,4-dithiepin- 1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor |
| 04/12/2001 | WO2000066144A3 Monthly doses of glycopeptide antibiotics for treatment of streptococcus pneumoniae infections |